索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]杨天云,王长谦.间充质干细胞及相关衍生治疗方法促进心肌 梗死后心肌修复[J].国际心血管病杂志,2022,03:141-144.
点击复制

间充质干细胞及相关衍生治疗方法促进心肌 梗死后心肌修复(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2022年03期
页码:
141-144
栏目:
综述
出版日期:
2022-06-20

文章信息/Info

Title:
-
作者:
杨天云; 王长谦
200011 上海交通大学医学院附属第九人民医院心内科
Author(s):
-
关键词:
心肌梗死; 间充质干细胞疗法; 组织工程技术; 脱细胞脂肪提取物疗法
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2022.03.004
文献标识码:
-
摘要:
间充质干细胞疗法可以改善心肌梗死后左心室功能，其主要作用包括抑制炎性 反应、抑制纤维化、促进血管生成以及刺激内源性心肌干细胞增殖分化。该疗法的不足之 处在于间充质干细胞移植效率低下，且长期安全性有待进一步证明，而由间充质干细胞衍生 的组织工程技术则有望弥补上述缺陷。
Abstract:
-

参考文献/References

[1] Karpov AA, Udalova DV, Pliss MG, et al. Can the outcomes of mesenchymal stem cell-based therapy for myocardial infarction be improved? Providing weapons and armour to cells[J]. Cell Prolif, 2017, 50(2):e12316.
[2] Lee S, Choi E, Cha MJ, et al. Cell adhesion and long-term survival of transplanted mesenchymal stem cells: a prerequisite for cell therapy[J]. Oxid Med Cell Longev, 2015, 2015:632902
[3] Ratajczak MZ, Kucia M, Jadczyk T, et al. Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: Can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies?[J]. Leukemia, 2012, 26(6):1166-1173.
[4] Mirotsou M, Jayawardena TM, Schmeckpeper J, et al. Paracrine mechanisms of stem cell reparative and regenerative actions in the heart[J]. J Mol Cell Cardiol, 2011, 50(2):280- 289.
[5] Hatzistergos KE, Quevedo H, Oskouei BN, et al. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation[J]. Circ Res, 2010, 107(7):913-922.
[6] Mazhari R, Hare JM. Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche[J]. Nat Clin Pract Cardiovasc Med, 2007, 4(Suppl 1):S21-S26.
[7] Teng X, Chen L, Chen W, et al. Mesenchymal stem cellderived exosomes improve the microenvironment of infarcted myocardium contributing to angiogenesis and antiinflammation[ J]. Cell Physiol Biochem, 2015, 37(6):2415- 2424.
[8] Frangogiannis NG. Regulation of the inflammatory response in cardiac repair[J]. Circ Res, 2012, 110(1):159-173.
[9] Miao C, Lei M, Hu W, et al. A brief review: the therapeutic potential of bone marrow mesenchymal stem cells in myocardial infarction[J]. Stem Cell Res Ther, 2017, 8(1):242.
[10] Li X, Zhao H, Qi C, et al. Direct intercellular communications dominate the interaction between adipose-derived MSCs and myofibroblasts against cardiac fibrosis[J]. Protein Cell, 2015, 6(10):735-745.
[11] Chen J, Liu Z, Hong MM, et al. Proangiogenic compositions of microvesicles derived from human umbilical cord mesenchymal stem cells[J]. PLoS One, 2014, 9(12):e115316..
[12] Shabbir A, Cox A, Rodriguez-Menocal LA, et al. Mesenchymal stem cell exosomes induce proliferation and migration of normal and chronic wound fibroblasts, and enhance angiogenesis in vitro[J]. Stem Cells Dev, 2015, 24(14):1635-1647.
[13] Liu XB, Wang JA, Ji XY, et al. Preconditioning of bone marrow mesenchymal stem cells by prolyl hydroxylase inhibition enhances cell survival and angiogenesis in vitro and after transplantation into the ischemic heart of rats[J]. Stem Cell Res Ther, 2014, 5(5):111.
[14] Kim PJ, Mahmoudi M, Ge X, et al. Direct evaluation of myocardial viability and stem cell engraftment demonstrates salvage of the injured myocardium[J]. Circ Res, 2015, 116(7):e40-e50.
[15] Tao B, Cui M, Wang C, et al. Percutaneous intramyocardial delivery of mesenchymal stem cells induces superior improvement in regional left ventricular function compared with bone marrow mononuclear cells in porcine myocardial infarcted heart[J]. Theranostics, 2015, 5(2):196-205.
[16] Silva GV, Litovsky S, Assad JA, et al. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model[J]. Circulation, 2005, 111(2):150-156.
[17] Hare JM, Fishman JE, Gerstenblith G, et al. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the Poseidon randomized trial[J]. JAMA, 2012, 308(22):2369-2379.
[18] Karpov AA, Udalova DV, Pliss MG. Can the outcomes of mesenchymal stem cell-based therapy for myocardial infarction be improved? Providing weapons and armour to cells[J]. Cell Prolif, 2017, 50(2):e12316.
[19] Lee EJ, Park SJ, Kang SK, et al. Spherical bullet formation via E-cadherin promotes therapeutic potency of mesenchymal stem cells derived from human umbilical cord blood for myocardial infarction[J]. Mol Ther, 2012, 20(7):1424-1433.
[20] Emmert MY, Wolint P, Wickboldt N, et al. Human stem cellbased three-dimensional microtissues for advanced cardiac cell therapies[J]. Biomaterials, 2013, 34(27):6339-6354.
[21] Ceccaldi C, Bushkalova R, Alfarano C, et al. Evaluation of polyelectrolyte complex-based scaffolds for mesenchymal stem cell therapy in cardiac ischemia treatment[J]. Acta Biomater, 2014, 10(2):901-911.
[22] Kai D, Wang QL, Wang HJ, et al. Stem cell-loaded nanofibrous patch promotes the regeneration of infarcted myocardium with functional improvement in rat model[J]. Acta Biomater, 2014, 10(6):2727-2738.
[23] Guex AG, Frobert A, Valentin J, et al. Plasma-functionalized electrospun matrix for biograft development and cardiac function stabilization[J]. Acta Biomater, 2014, 10(7):2996- 3006.
[24] Scarritt ME, Pashos NC, Bunnell BA. A review of cellularization strategies for tissue engineering of whole organs[J]. Front Bioeng Biotechnol, 2015, 3:43.
[25] Oberwallner B, Brodarac A, Choi YH, et al. Preparation of cardiac extracellular matrix scaffolds by decellularization of human myocardium[J]. J Biomed Mater Res A, 2014, 102(9):3263-3272.
[26] Yu Z, Cai Y, Deng M, et al. Fat extract promotes angiogenesis in a murine model of limb ischemia: a novel cell-free therapeutic strategy[J]. Stem Cell Res Ther, 2018, 9(1):294.
[27] Svystonyuk DA, Ngu JM, Mewhort HE, et al. Fibroblast growth factor-2 regulates human cardiac myofibroblastmediated extracellular matrix remodeling[J]. J Transl Med, 2015, 13:147.
[28] Fan Z, Xu Z, Niu H, et al. Spatiotemporal delivery of basic fibroblast growth factor to directly and simultaneously attenuate cardiac fibrosis and promote cardiac tissue vascularization following myocardial infarction[J]. J Control Release, 2019, 311-312:233-244.
[29] Lee HW, Ahmad M, Weldrick JJ, et al. Effects of exercise training and TrkB blockade on cardiac function and BDNFTrkB signaling postmyocardial infarction in rats[J]. Am J Physiol Heart Circ Physiol, 2018, 315(6):H1821-H1834.
[30] Zheng H, Yu Z, Deng M, et al. Fat extract improves fat graft survival via proangiogenic, anti-apoptotic and pro-proliferative activities[J]. Stem Cell Res Ther, 2019, 10(1):174.

备注/Memo

备注/Memo:
通信作者：王长谦，E-mail: wcqian@hotmail.com
更新日期/Last Update: 2022-06-20